Document Detail


Uterine atony: definition, prevention, nonsurgical management, and uterine tamponade.
MedLine Citation:
PMID:  19324236     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Uterine atony, or failure of the uterus to contract following delivery, is the most common cause of postpartum hemorrhage. This review serves to examine the prevention and treatment of uterine atony, including risk-factor recognition and active management of the third stage of labor. A range of uterotonic agents will be compared for efficacy, safety, and ease of administration. Oxytocin and ergot alkaloids represent the cornerstone of uterotonic therapy, while prostaglandin therapy has been studied more recently as an attractive alternative, particularly for resource-poor settings. Newer supplementary medical therapies, such as recombinant factor VII and hemostatic agents, and adjunctive nonsurgical methods aimed at achieving uterine tamponade will be evaluated.
Authors:
Fionnuala Breathnach; Michael Geary
Related Documents :
20837346 - First clinical experience of ankaferd bloodstopper as a hemostatic agent in partial nep...
21883336 - Fairness and nanotechnology concern.
1500366 - Anthelmintic activity of dioxapyrrolomycin.
11570216 - Synthesis of some new derivatives of thiazolo-[3,2-a]pyrimidine-3,5,7(2h)-trione of pot...
304396 - Ecological studies of bulinus rohlfsi, the intermediate host of schistosoma haematobium...
8680196 - Homoeopathy: 3. everyday uses for all the family.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in perinatology     Volume:  33     ISSN:  1558-075X     ISO Abbreviation:  Semin. Perinatol.     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-03-27     Completed Date:  2009-06-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7801132     Medline TA:  Semin Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  82-7     Citation Subset:  IM    
Affiliation:
Division of Maternal Fetal Medicine, Columbia University Medical Center, New York, NY 10708, USA. fmb2108@columbia.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
Hemostatics / therapeutic use
Humans
Hysterotomy
Oxytocics / therapeutic use
Pregnancy
Risk Factors
Suture Techniques
Uterine Inertia / prevention & control,  therapy*
Chemical
Reg. No./Substance:
0/Hemostatics; 0/Oxytocics

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Obstetric hemorrhage.
Next Document:  Abnormal placentation.